Ply attachment for multiply lotioned tissue products is accomplished by distributing thermoplastic particles between the plies and melting the thermoplastic particles to bond together the fibers of the two plies.

Patent
   4806418
Priority
Aug 11 1986
Filed
Nov 24 1987
Issued
Feb 21 1989
Expiry
Aug 11 2006
Assg.orig
Entity
Large
13
4
all paid
1. A tissue comprising two lotion-containing plies bonded together where lotion is present by a melted thermoplastic, said thermoplastic being present in an amount less than about 0.0025 grams per square inch of bonded surface.
2. The tissue of claim 1 wherein the amount of thermoplastic is about 0.0006 grams per square inch or less.
3. The tissue of claim 1 wherein the tissue is a facial tissue.

This is a continuation of co-pending application Ser. No. 895,074 filed on Aug. 11, 1986, now abandoned.

In the manufacture of facial tissue, two-ply products are typically held together by crimping the edges of the two plies. However, recently some products have been developed which contain lotions or other ingredients which act to inhibit ply attachment by crimping. For example, U.S. Pat. No. 4,481,243 to Allen describes a lotioned tissue product which is designed to sooth the user's skin. Because the lotion prevents successful edge crimping, the lotion is applied only to areas of the tissue which are not to be crimped, namely the center of the tissue. This of course leaves areas of the tissue which are untreated and are potentially irritating to the user.

Therefore there is a need for a method of ply attachment which is not sensitive to the ingredients contained within treated tissues.

In general, the invention resides in a method for attaching together two plies of tissue, such as facial and bath tissue and the like, comprising: (a) distributing thermoplastic particles over one surface of a first tissue ply; (b) bringing a second tissue ply into contacting relationship with the thermoplastic particle-containing surface of the first tissue ply; (c) melting or softening the thermoplastic particles; and (d) solidifying the melted of softened thermoplastic particles whereby the first and second tissue plies become bonded together. Although this method can be used to attach together two or more plies of any tissue, it is particularly advantageous for attaching together tissue plies wherein one or both of the plies contain ingredients such as emollients, lotions, oils, and the like, the presence of which prevents attachment by crimping. For purposes herein, these various ingredients are lumped together into the single term "lotion."

The thermoplastic particles can be distributed over the surface in any desired pattern, although a light overall dusting of one ply is preferred for convenience. A suitable means for distributing the particles is described in U.S. Pat. No. 4,561,380 to Mulder et al., which is incorporated herein by reference. However, it is within the scope of this invention that the thermoplastic particles be distributed on or within the ply or plies in any suitable manner, such as by incorporating the particles into the furnish and forming the plies with the thermoplastic particles contained therein. Alternatively the thermoplastic particles can be applied to the surface of one or both plies at distinct spaced-apart spots or in a line pattern.

In order for ply attachment (bonding) to occur, the second ply must be brought into a contacting relationship with the thermoplastic particle-containing surface of the first ply. The necessary contact, heating, and cooling is most easily accomplished in a heated nip, in which the thermoplastic particles are melted or otherwise sufficiently softened and cooled to bond the plies together. Because the molten thermoplastic envelops the individual fibers of both plies, upon hardening the two plies become bonded together. As such this method is effective regardless of the presence of fiber coatings which would otherwise prevent intra-fiber chemical bonding. Although a heated nip is the most convenient method of achieving ply attachment in accordance with this invention, other means of melting the thermoplastic polymer are also within the scope of this invention, such as the use of ultrasonic bonding or radio frequency sealing.

The particular thermoplastic polymers preferred for use in the method of this invention are polyethylene and polypropylene because of their availability and low cost. However, any thermoplastic polymer is suitable from a purely technical standpoint. The particle size of the thermoplastic particle is of some importance in that the particles must be small enough to avoid adverse effects on the perceived softness of the tissue product. In general, the thermoplastic particles should be small enough to pass through a 20 mesh screen. Particles larger than 20 mesh can be detected in the tissue. In addition, when larger particles are present, the melted thermoplastic may penetrate the tissue web and cause blocking when the web is wound onto a roll. (For purposes herein, mesh size is as defined in ASTM D-1921.) A suitable form of thermoplastic particle is commercially available under the name "Microthene" from U.S.I. Corporation. This product is available in different grades of a very fine polyolefin powder having different mesh sizes.

For facial tissue, the particle distribution over the surface of the first ply should be less than about 0.0025 grams per square inch in order to avoid an overly stiff product. The particle density will depend greatly on the particle size and the desired bond strength between the plies. A particle density of about 0.0006 grams per square inch or less is preferred for facial and bath tissue, but in any particular case the particle density will depend upon the nature of the product and its intended use. Heavier basis weight products, such as wipes and paper towels, may need stronger ply attachment and can use higher particle densities because any resulting increase in stiffness is less noticeable or critical.

In order to further illustrate the method of this invention, a commercially available lotion-treated ply of facial tissue was dusted with a low density polyethylene powder. The lotion contained mineral oil, cetearyl alcohol, and steareth-2 and was present in the ply at a level of about 12 percent by weight. The polyethylene powder was Microthene MN714, which is a 50 mesh material. The powder was evenly distributed over the surface of the lotion-treated tissue using a small shaker tray. A second lotion-treated ply was laid on top of the first and briefly compressed with a heated laboratory iron (280° F. surface temperature). The iron caused the polyethylene powder to melt and bind the two plies together. This procedure was repeated for the following powder densities (grams per square inch): 0.000625, 0.00125, 0.0025, 0.00625, 0.0125 and 0.01875. In all cases the ply bonding was strong enough to tear the plies when separated, even at the lowest level of powder addition, illustrating the effectiveness of this method.

It must also be pointed out that the method of this invention can be utilized to produce multiply tissue products wherein the lotion is applied simultaneously with the thermoplastic particles. For example, encapsulated lotions are available in microbead form which can be applied to the tissue with the thermoplastic bonding particles. In this case, the lotion is released when the two plies are bonded together.

It will be appreciated that the foregoing examples, shown for purposes of illustration, are not to be construed as limiting the scope of this invention.

Sigl, Wayne C.

Patent Priority Assignee Title
5558873, Jun 21 1994 Kimberly-Clark Worldwide, Inc Soft tissue containing glycerin and quaternary ammonium compounds
5601871, Feb 06 1995 Kimberly-Clark Worldwide, Inc Soft treated uncreped throughdried tissue
5614293, Feb 06 1995 Kimberly-Clark Worldwide, Inc Soft treated uncreped throughdried tissue
5650218, Feb 06 1995 Kimberly-Clark Worldwide, Inc Soft treated tissue
5665426, Feb 06 1995 Kimberly-Clark Worldwide, Inc Soft treated tissue
5720966, Dec 19 1994 The Procter & Gamble Company Medicated tissue paper product
5885697, Dec 17 1996 Kimberly-Clark Worldwide, Inc Soft treated tissue
6136422, Apr 05 1996 JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, AS AGENT Spray bonded multi-ply tissue
6635134, Apr 05 1996 JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, AS AGENT Method of producing a spray bonded multi-ply tissue product
6924042, Nov 20 2001 SCA Hygiene Products GmbH Multi-ply planar product including adhesively bonded fibrous plies
7201815, Sep 02 2003 H B FULLER COMPANY Paper laminates manufactured using foamed adhesive systems
7846281, Sep 02 2003 H B FULLER COMPANY Paper laminates manufactured using foamed adhesive systems
9649830, Dec 03 2008 The Procter & Gamble Company Bonded fibrous sanitary tissue products and methods for making same
Patent Priority Assignee Title
3654020,
3682738,
4189896, Aug 25 1978 Procter & Gamble Company, The Liquid impregnating system
4481243, Jan 05 1984 The Procter & Gamble Company; PROCTER & GAMBLE COMPANY THE Pattern treated tissue paper product
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Nov 24 1987Kimberly-Clark Corporation(assignment on the face of the patent)
Nov 30 1996Kimberly-Clark CorporationKimberly-Clark Worldwide, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0085190919 pdf
Date Maintenance Fee Events
Mar 03 1992M183: Payment of Maintenance Fee, 4th Year, Large Entity.
Apr 23 1992ASPN: Payor Number Assigned.
Mar 22 1996M184: Payment of Maintenance Fee, 8th Year, Large Entity.
Jul 31 2000M185: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Feb 21 19924 years fee payment window open
Aug 21 19926 months grace period start (w surcharge)
Feb 21 1993patent expiry (for year 4)
Feb 21 19952 years to revive unintentionally abandoned end. (for year 4)
Feb 21 19968 years fee payment window open
Aug 21 19966 months grace period start (w surcharge)
Feb 21 1997patent expiry (for year 8)
Feb 21 19992 years to revive unintentionally abandoned end. (for year 8)
Feb 21 200012 years fee payment window open
Aug 21 20006 months grace period start (w surcharge)
Feb 21 2001patent expiry (for year 12)
Feb 21 20032 years to revive unintentionally abandoned end. (for year 12)